Tapewire

Nasdaq · USD

BVS

Bioventus Inc.

Export transactions ↓
Tapewire entity
4996
SEC CIK
0001665988
Parsed reports
251

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 11, 2022 Filed Feb 16, 2022 02:15 UTC Exercise / conversionRestricted Stock Units · Derivative 9,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006535 · doc4.xml · derivative · entry 2

Cowdy Philip G. · CIK 0001679773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 9,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vested on February 11, 2022.

F2 · derivative.expiration_date: The restricted stock units vested on February 11, 2022.

Read SEC document
February 11, 2022 Filed Feb 16, 2022 02:15 UTC Exercise / conversionClass A Common Stock 9,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006535 · doc4.xml · nonDerivative · entry 1

Cowdy Philip G. · CIK 0001679773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 11, 2022 Filed Feb 16, 2022 02:17 UTC
Nosenzo JohnChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,470 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006538 · doc4.xml · derivative · entry 3

Nosenzo John · CIK 0001835973 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 1,470 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F4 · derivative.exercise_date: The restricted stock units vested on February 11, 2022.

F4 · derivative.expiration_date: The restricted stock units vested on February 11, 2022.

Read SEC document
February 11, 2022 Filed Feb 16, 2022 02:17 UTC
Nosenzo JohnChief Commercial Officer
Exercise / conversionClass A Common Stock 1,470 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006538 · doc4.xml · nonDerivative · entry 1

Nosenzo John · CIK 0001835973 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 11, 2022 Filed Feb 16, 2022 02:14 UTC Exercise / conversionRestricted Stock Units · Derivative 9,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006534 · doc4.xml · derivative · entry 2

STALNECKER SUSAN M · CIK 0001221375 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 9,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vested on February 11, 2022.

F2 · derivative.expiration_date: The restricted stock units vested on February 11, 2022.

Read SEC document
February 11, 2022 Filed Feb 16, 2022 02:14 UTC Exercise / conversionClass A Common Stock 9,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006534 · doc4.xml · nonDerivative · entry 1

STALNECKER SUSAN M · CIK 0001221375 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 20:31 UTC Exercise / conversionPhantom Profit Units · Derivative 38,288 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006324 · doc4.xml · derivative · entry 2

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 38,288 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 14, 2022 20:31 UTC Exercise / conversionClass A Common Stock 38,288 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006324 · doc4.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:43 UTC
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
Exercise / conversionPhantom Profit Units · Derivative 191,708 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006333 · doc4.xml · derivative · entry 3

Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 191,708 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:43 UTC
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
Tax withholdingClass A Common Stock 73,915 $12.88 $952,025.20
Disclosure

SEC source: 0000899243-22-006333 · doc4.xml · nonDerivative · entry 2

Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,793

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:43 UTC
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER
Exercise / conversionClass A Common Stock 191,708 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006333 · doc4.xml · nonDerivative · entry 1

Pavesio Alessandra · CIK 0001835185 · SVP & CHIEF SCIENCE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:41 UTC
Nosenzo JohnCHIEF COMMERCIAL OFFICER
Exercise / conversionPhantom Profit Units · Derivative 66,139 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006332 · doc4.xml · derivative · entry 3

Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 66,139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:41 UTC
Nosenzo JohnCHIEF COMMERCIAL OFFICER
Tax withholdingClass A Common Stock 24,205 $12.88 $311,760.40
Disclosure

SEC source: 0000899243-22-006332 · doc4.xml · nonDerivative · entry 2

Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,434

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:41 UTC
Nosenzo JohnCHIEF COMMERCIAL OFFICER
Exercise / conversionClass A Common Stock 66,139 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006332 · doc4.xml · nonDerivative · entry 1

Nosenzo John · CIK 0001835973 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,639

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:35 UTC Exercise / conversionPhantom Profit Units · Derivative 65,581 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006327 · doc4.xml · derivative · entry 3

Anglum Gregory O. · CIK 0001680271 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 65,581 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:35 UTC Tax withholdingClass A Common Stock 19,674 $12.88 $253,401.12
Disclosure

SEC source: 0000899243-22-006327 · doc4.xml · nonDerivative · entry 2

Anglum Gregory O. · CIK 0001680271 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,907

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:35 UTC Exercise / conversionClass A Common Stock 65,581 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006327 · doc4.xml · nonDerivative · entry 1

Anglum Gregory O. · CIK 0001680271 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:37 UTC
D'Adamio AnthonySVP & General Counsel
Exercise / conversionPhantom Profit Units · Derivative 21,165 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-006329 · doc4.xml · derivative · entry 3

D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 21,165 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.exercise_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

F1 · derivative.expiration_date: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:37 UTC
D'Adamio AnthonySVP & General Counsel
Tax withholdingClass A Common Stock 6,599 $12.88 $84,995.12
Disclosure

SEC source: 0000899243-22-006329 · doc4.xml · nonDerivative · entry 2

D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,566

Read SEC document
February 10, 2022 Filed Feb 15, 2022 01:37 UTC
D'Adamio AnthonySVP & General Counsel
Exercise / conversionClass A Common Stock 21,165 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-006329 · doc4.xml · nonDerivative · entry 1

D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:10 UTC GrantRestricted Stock Units · Derivative 1,157 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001750 · doc4.xml · derivative · entry 1

McMurry-Heath Michelle · CIK 0001904156 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,157

Underlying: Class A Common Stock · 1,157 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

F2 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantRestricted Stock Units · Derivative 2,895 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 8

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,895

Underlying: Class A Common Stock · 2,895 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock

F5 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 261,794 Not disclosed Strike: $12.71 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 7

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,794

Underlying: Class A Common Stock · 261,794 shares

Expires 2030-06-29

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 89,001 Not disclosed Strike: $7.78 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 6

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,001

Underlying: Class A Common Stock · 89,001 shares

Expires 2030-06-29

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 347,323 Not disclosed Strike: $5.63 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 5

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,323

Underlying: Class A Common Stock · 347,323 shares

Expires 2030-05-13

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 34,905 Not disclosed Strike: $12.27 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 4

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,905

Underlying: Class A Common Stock · 34,905 shares

Expires 2029-11-22

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 19,634 Not disclosed Strike: $4.13 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 3

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,634

Underlying: Class A Common Stock · 19,634 shares

Expires 2026-02-04

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 6,544 Not disclosed Strike: $3.33 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 2

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,544

Underlying: Class A Common Stock · 6,544 shares

Expires 2023-12-03

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:17 UTC GrantStock Option (Right to Buy) · Derivative 26,179 Not disclosed Strike: $7.57 Not disclosed
Disclosure

SEC source: 0000899243-21-042368 · doc4.xml · derivative · entry 1

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,179

Underlying: Class A Common Stock · 26,179 shares

Expires 2025-02-03

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement);

F3 · price: (continued from footnote 2) by (B) the Option Exchange Ratio (as defined in the Merger Agreement), rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: This option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:20 UTC
Beyer PatDirector
GrantRestricted Stock Units · Derivative 2,895 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-042370 · doc4.xml · derivative · entry 2

Beyer Pat · CIK 0001627985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,895

Underlying: Class A Common Stock · 2,895 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F5 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (I) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in teach case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

F5 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (I) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in teach case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:20 UTC
Beyer PatDirector
GrantStock Option (Right to Buy) · Derivative 34,906 Not disclosed Strike: $10.94 Not disclosed
Disclosure

SEC source: 0000899243-21-042370 · doc4.xml · derivative · entry 1

Beyer Pat · CIK 0001627985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,906

Underlying: Class A Common Stock · 34,906 shares

Expires 2031-05-14

F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each option to purchase Misonix Inc. ("Misonix") common stock (a "Misonix Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into an option to acquire the number of shares of Class A common stock of the Issuer (an "Issuer Option") equal to the product of (i) the number of shares of Misonix common stock subject to such Misonix Option immediately prior to the First Effective Time (as defined in the Merger Agreement); by (B) the Option Exchange Ratio (as defined in the Merger Agreement),

F3 · price: (Continued from Footnote 2) rounded down to the nearest whole number of shares of the Issuer's Class A common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Misonix Option by the Option Exchange Ratio, rounded up to the nearest whole cent.

F1 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
October 29, 2021 Filed Apr 28, 2022 20:24 UTC GrantClass A Common Stock 2,780,923 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-015851 · doc4.xml · nonDerivative · entry 1

Vizirgianakis Stavros G. · CIK 0001559834 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,780,923

F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each share of Misonix Inc. ("Misonix") common stock (a "Misonix Option") that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into the right to receive a per share amount (the "Merger Consideration") equal to either an amount in cash equal to $28.00 or 1.6839 validly issued, fully paid and non-assessable shares of the Company's Class A Common Stock, $0.001 par value per share ("Bioventus Shares"). The transaction was exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3 promulgated thereunder.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 13:22 UTC
Reali Kenneth MichaelDirector · CHIEF EXECUTIVE OFFICER
PurchaseClass A Common Stock 1,800 $14.81 $26,658.00
Disclosure

SEC source: 0000899243-21-035518 · doc4.xml · nonDerivative · entry 1

Reali Kenneth Michael · CIK 0001480801 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,175

Read SEC document
July 15, 2021 Filed Jul 19, 2021 22:41 UTC GrantRestricted Stock Units · Derivative 5,440 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-028863 · doc4.xml · derivative · entry 1

Ladone Mary Kay · CIK 0001760737 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,440

Underlying: Class A Common Stock · 5,440 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

F2 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:34 UTC GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014839 · doc4.xml · derivative · entry 1

SUTTER MARTIN P · CIK 0001017832 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 16:35 UTC GrantRestricted Stock Units · Derivative 40,573 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014840 · doc4.xml · derivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,573

Underlying: Class A Common Stock · 40,573 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:40 UTC GrantRestricted Stock Units · Derivative 23,416 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014848 · doc4.xml · derivative · entry 1

STALNECKER SUSAN M · CIK 0001221375 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,416

Underlying: Class A Common Stock · 23,416 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:38 UTC
Pavesio AlessandraSVP & Chief Science Officer
GrantStock Options · Derivative 4,900 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0000899243-21-014846 · doc4.xml · derivative · entry 3

Pavesio Alessandra · CIK 0001835185 · SVP & Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,900

Underlying: Class A Common Stock · 4,900 shares

Expires 2031-03-31

F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:38 UTC
Pavesio AlessandraSVP & Chief Science Officer
GrantRestricted Stock Units · Derivative 61,476 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014846 · doc4.xml · derivative · entry 2

Pavesio Alessandra · CIK 0001835185 · SVP & Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,476

Underlying: Class A Common Stock · 61,476 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:35 UTC
Anglum Gregory O.SVP & General Counsel
GrantStock Options · Derivative 9,100 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0000899243-21-014841 · doc4.xml · derivative · entry 3

Anglum Gregory O. · CIK 0001680271 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,100

Underlying: Class A Common Stock · 9,100 shares

Expires 2031-03-31

F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:35 UTC
Anglum Gregory O.SVP & General Counsel
GrantRestricted Stock Units · Derivative 96,876 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014841 · doc4.xml · derivative · entry 2

Anglum Gregory O. · CIK 0001680271 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,876

Underlying: Class A Common Stock · 96,876 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:37 UTC
D'Adamio AnthonySVP & General Counsel
GrantStock Options · Derivative 9,500 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0000899243-21-014843 · doc4.xml · derivative · entry 3

D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Class A Common Stock · 9,500 shares

Expires 2031-03-31

F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:37 UTC
D'Adamio AnthonySVP & General Counsel
GrantRestricted Stock Units · Derivative 37,476 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014843 · doc4.xml · derivative · entry 2

D'Adamio Anthony · CIK 0001835184 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,476

Underlying: Class A Common Stock · 37,476 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:33 UTC GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014835 · doc4.xml · derivative · entry 1

Parker David J · CIK 0001299047 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:32 UTC
NOHRA GUY PDirector
GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014834 · doc4.xml · derivative · entry 1

NOHRA GUY P · CIK 0001198330 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:31 UTC GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014833 · doc4.xml · derivative · entry 1

Cowdy Philip G. · CIK 0001679773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:31 UTC
Reali Kenneth MichaelDirector · Chief Executive Officer
GrantStock Options · Derivative 30,000 $0.00 Strike: $15.23 $0.00
Disclosure

SEC source: 0000899243-21-014831 · doc4.xml · derivative · entry 2

Reali Kenneth Michael · CIK 0001480801 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Class A Common Stock · 30,000 shares

Expires 2031-03-31

F1 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on April 1, 2022.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:31 UTC GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014830 · doc4.xml · derivative · entry 1

NEELS GUIDO J · CIK 0001222362 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 20:31 UTC
Nosenzo JohnChief Commercial Officer
GrantRestricted Stock Units · Derivative 106,485 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-014832 · doc4.xml · derivative · entry 2

Nosenzo John · CIK 0001835973 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,485

Underlying: Class A Common Stock · 106,485 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2 · derivative.exercise_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

F2 · derivative.expiration_date: The restricted stock units vest on April 1, 2022 and have no expiration date.

Read SEC document
April 01, 2021 Filed Apr 14, 2026 22:19 UTC Amendment GrantRestricted Stock Units · Derivative 2,700 $0.00 $0.00
Disclosure

SEC source: 0001679773-26-000004 · wk-form4a_1776205186.xml · derivative · entry 1

Cowdy Philip G. · CIK 0001679773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 2,700 shares

Expires not disclosed

F1 · security: On April 5, 2021, the Issuer inadvertently filed a Form 4 reporting a grant of restricted stock units that were not accepted by the Reporting Person. As of April 1, 2021, the Reporting Person held no non-derivative or derivative securities of the Issuer.

F2 · derivative.exercise_price: None.

F2 · derivative.exercise_date: None.

F2 · derivative.expiration_date: None.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.